Moleculin Biotech, Inc. Sales Agreements
3 Contracts & Agreements
- At Market Issuance Sales Agreement, dated July 17, 2020, by and among the Company and Oppenheimer & Co. Inc (Filed With SEC on July 17, 2020)
- At Market Issuance Sales Agreement, dated July 23, 2019, by and among the Company and Oppenheimer & Co. Inc (Filed With SEC on July 24, 2019)
- At Market Issuance Sales Agreement, dated September 15, 2017, by and among the Company, Roth Capital Partners, LLC and National Securities Corporation (Filed With SEC on September 15, 2017)
